Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy

Urology

Volumn 61, Issue 2, 2003, Pages 380-385

  Shinghal, Rajesh ^a   Yemoto, Cheryl ^a   McNeal, John E ^a   Brooks, James D ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ANALYTIC METHOD; ANTIGEN DETECTION; ARTICLE; ASSAY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; FOLLOW UP; GROWTH RATE; HUMAN; HUMAN TISSUE; MALE; PATIENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECURRENT CANCER;

EID: 0037320934     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02254-9     Document Type: Article

References (24)

1. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. Urol Clin North Am. 28:2001;555-565.
2. Zincke H., Oesterling J.E., Blute M.L., et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol. 152:1994;1850-1857.
3. Catalona W.J., Smith D.S. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer intermediate-term results . J Urol. 160:1998;2428-2434.
4. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J Urol. 167:2002;528-534.
5. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597.
6. Prestigiacomo A.F., Stamey T.A. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol. 152:1994;1515-1519.
7. Yu H., Diamandis E.P., Wong P., et al. Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microgram/liter. J Urol. 157:1997;913-918.
8. Ellis W.J., Vesella R.L., Noteboom J.L., et al. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific assay. Urology. 50:1997;573-579.
9. Haese A., Huland E., Graefen M., et al. Ultrasensitive detection of prostate specific antigen in the follow-up of 422 patients after radical prostatectomy. J Urol. 161:1999;1206-1211.
10. Stamey T.A., McNeal J.E., Yemoto C.M., et al. Biological determinants of cancer progression in men with prostate cancer. JAMA. 281:1999;1395-1400.
11. Han M., Partin A.W., Piantadosi S., et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol. 166:2001;416-419.
12. Stamey T.A., Freiha F.S., McNeal J.E., et al. Localized prostate cancer relationship of tumor volume to clinical significance for treatment of prostate cancer . Cancer Suppl. 71:1993;933-938.
13. Witherspoon L.R., Lapeyrolerie T. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol. 157:1997;1322-1328.
14. Amling C.L., Bergstrahl E.J., Blute M.L., et al. Defining prostate specific antigen progression after radical prostatectomy what is the most appropriate cut point? J Urol. 165:2001;1146-1151.
15. Stamey T.A., Villers A.A., McNeal J.E., et al. Positive surgical margins at radical prostatectomy importance of the apical dissection . J Urol. 143:1990;1166-1172.
16. Myers R.P., Goellner J.R., Cahill D.R. Prostate shape, external striated urethral sphincter and radical prostatectomy the apical dissection . J Urol. 138:1987;543-550.
17. Shah O., Melamed J., Lepor H. Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol. 165:2001;1943-1948.
18. Ponthieu A., Delgrande J., Ivaldi A. Preoperative biopsy of the sub-apical urethra during prostatectomy for cancer. Prog Urol. 6:1996;250-255.
19. Lepor H., Chan S., Melamed J. The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of the bladder neck. J Urol. 160:1998;2435-2439.
20. Djavan B., Sesterhann I., Hruby S., et al. Benign prostatic glands in the surgical margin of radical retropubic prostatectomies redefining PSA nadir . J Urol. 163:2000;A624.
21. Oesterling J.E., Tekchandani A.H., Martin S.K., et al. The periurethral glands do not significantly influence prostate specific antigen concentration. J Urol. 155:1996;1658-1660.
22. Ornstein D.K., Colberg J.W., Virgo K.S., et al. Evaluation and management of men whose radical prostatectomies failed results of an international survey . Urology. 52:1998;1047-1052.
23. Messing E.M., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 341:1999;1781-1788.
24. Immediate versus deferred treatment for advanced prostatic cancer initial results of the Medical Research Council Trial . Br J Urol. 79:1997;235-246.